Hairy-cell leukemia and α-interferon treatment: Long-term responders

Haematologica

Volumn 82, Issue 2, 1997, Pages 152-155

  Zinzani, Pier Luigi ^a,c   Lauria, Francesco ^b   Salvucci, Marzia ^a   Rondelli, Damiano ^a   Raspadori, Donatella ^a   Bendandi, Maurizio ^a   Magagnoli, Massimo ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

IFN; Hairy cell leukemia; Treatment

Indexed keywords

ALPHAN1 INTERFERON; CLADRIBINE; PENTOSTATIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HAIRY CELL LEUKEMIA; HEMOLYTIC ANEMIA; HUMAN; LEUKEMIA; MALE; SPLENOMEGALY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031465777     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bouroncle BA, Wiseman BK, Doan LA. Leukemic reticuloendotheliosis. Blood 1958; 13:609-30.
2. Catovsky D, Pettit JE, Galton DAG, et al. Leukaemic reticuloendotheliosis (hairy-cell leukaemia): a distinct clinico-pathological entity. Br J Haematol 1974; 26:9-27.
3. Jansen J, Hermans J. Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer 1981; 47:2066-76.
4. Golomb HM, Vardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 1983; 61:349-52.
5. Quesada JR, Reuben J, Manning JT, et al. α-interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984; 310:15-8.
6. Foon KA, Maluish AE, Abrams PG, et al. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia: therapeutic and immunologic results. Am J Med 1986; 80:351-6.
7. Flandrin G, Sigaux F, Castagne S, et al. Treatment of hairy cell leukemia with recombinant α-interferon: quantitative study of bone marrow changes during the first months of treatment. Blood 1986; 67:817-21.
8. Ratain MJ, Golomb HM, Vardiman JW, et al. Treatment of hairy cell leukemia with recombinant α-2 interferon. Blood 1985; 65:644-8.
9. Lauria F, Foa R, Raspadori D, et al. Treatment of hairy cell leukemia with α-interferon. Eur J Cancer Clin Oncol 1988; 24:195-200.
10. Jacobs AD, Champlin RE, Golde DW. Recombinant α-2 interferon for hairy cell leukemia. Blood 1985; 65:1017-20.
11. Zinzani PL, Lauria F, Raspadori D, et al. Results in hairy-cell leukemia patients treated with α-interferon: predictive prognostic factors. Eur J Haematol 1992; 49:133-7.
12. Berman E, Heller C, Kempin S, et al. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon α-2a. Blood 1990; 75:839-42.
13. Golomb HM, Ratain MJ, Feffer A, et al. Low dose interferon α-2B for the induction of remission of hairy cell leukemia: a multi-institutional study of 49 patients. Leuk Lymphoma 1992; 5:335-40.
14. Spiers ASD, Moore D, Cassileth PA, et al. Remissions in hairy-cell leukemia: with pentostatin (2′-deoxycoformycin). N Engl J Med 1987; 316:825-30.
15. Kraut EH, Bouroncle BA, Grever MR. Pentostatin in the treatment of advanced hairy cell leukemia. J Clin Oncol 1989; 7:168-72.
16. Johnston JB, Eisenhauer E, Corbett WEN, et al. Efficacy of 2-deoxycoformycin in hairy cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group. J Natl Cancer Inst 1988; 80:765-9.
17. Grever M, Kopechy K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon α-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 1995; 13:974-82.
18. Piro LD, Carrera CJ, Carsont DA, et al. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 332:1117-21.
19. Estey EH, Kurzrock R, Kantarjian HM, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 1992; 79:882-7.
20. Lauria F, Benfenati D, Raspadori D, et al. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Leuk Lymphoma 1993; 11:399-404.
21. Seymour JF, Kurzrock R, Freireich EJ, et al. 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 1994; 83:2906-10.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
23. Italian Cooperative Group for Hairy Cell Leukemia (ICGHCL). Long-term results of interferon treatment in hairy cell leukemia. Leuk Lymphoma 1994; 14:457-64.
24. Spielberger RT, Mick R, Ratain MJ, et al. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma 1994; 14(Suppl 1):89-93.
25. Troussard X, Flandrin G. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment. Leuk Lymphoma 1994; 14(Suppl 1):99-105.
26. Rai KR, Davey F, Peterson B, et al. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. Leukemia 1995; 9:1116-20.
27. Jacobs RH, Vokes EE, Golomb HM. Second malignancies in hairy cell leukemia. Cancer 1985; 56:1462-7.
28. Kampmeier P, Spielberger R, Dickstein J, et al. Increased incidence of second neoplasms in patients treated with interferon α-2b for hairy cell leukemia: a clinicopathologic assessment. Blood 1994; 83:2931-8.
29. Molica S, De Rossi G, Luciani M, Levato D. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Haematologica 1995; 80:176-83.
30. Andriani A, Bibas M, Callea V, et al. Autoimmune hemolytic anemia during α-interferon treatment in nine patients with hematological disease. Haematologica 1996; 81:258-60.